ARTICLE | Clinical News
Generx cardionovo alferminogene tadenovec: Interim Phase III data
February 16, 2015 8:00 AM UTC
Interim data from 11 patients with myocardial ischemia due to coronary artery disease (CAD) in the open-label, Russian Phase III ASPIRE trial showed that an intracoronary infusion of Generx led to a 2...